News

Industry is not waiting for action in Washington

As payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical

Design choices can make a difference in a crowded market

Orphan drug development and marketing have important distinct requirements for R&D, regulatory and marketing

Fifth annual 'Pain in the (Supply) Chain' survey finds continuing balancing act between growth and cost control

PCMA issues a report, 'Should Independent Drugstores Be More Accountable?'

Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation

Antares Vision Srl partners with Xyntek, Inc. for US market

Expects to have 22 states onboard in near future, preventing 'doctor shopping' and other abuses

GPhA/IMS Health data-sharing project clears FTC hurdle; meanwhile, Congressional committees take their own stabs at the problem

Action adds to the increasing number of global healthcare-distribution pathways

Goal is to combine drug information with e-prescribing with electronic health record (EHR) systems

Online 'pharmacies' selling diverted or bogus products, illicitly, will be countered by trade groups, leading e-commerce vendors

Physicians Interactive partners with Allscripts to ease delivery of coupons

Latest acquisition is Reglera, leading consulting firm for med devices and human tissue products

Analysis of 'pharmacy related waste' finds $408 billion in potential annual savings

Campbell Alliance's new market-research unit publishes a quarterly Trends Report

Implications for pharma are in continuing pricing pressure, and preferences for distribution channels

The race for capturing the online attention of prescribers gets more competitive

Arkansas Best will build on Panther's time-definite and cold-chain services for life sciences

Latest Manhattan Research market study finds little growth in social media usage; also, the rise of the 'three screen' physician

Analysis of 'pharmacy related waste' finds $408 billion in potential annual savings

New sample reporting requirements will be a focus of this year's meeting

Despite the lack of headlines today as compared to late last year, the drug-shortage situation has not improved. FDA, congressional and industry actions are beginning to change the dynamic

Prospects for international policing of counterfeit drugs is dim

Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare